CCL16
Hemokinski (C-C motivni) ligand 16 | |||||||
---|---|---|---|---|---|---|---|
Identifikatori | |||||||
Simbol | CCL16 | ||||||
Alt. simboli | SCYA16, NCC-4, SCYL4, LEC, HCC-4, LMC, LCC-1, CKb12, Mtn-1 | ||||||
NCBI gen | 6360 | ||||||
HGNC | 10614 | ||||||
OMIM | 601394 | ||||||
RefSeq | NM_004590 | ||||||
UniProt | O15467 | ||||||
Ostali podaci | |||||||
Lokus | Hrom. 17q11.2 | ||||||
|
Hemokinski (C-C motivni) ligand 16(CCL16) jest malicitokinkoji pripada porodici CChemokinai poznat je pod nekolikopseudonima,uključujući hemokine koji eksprimirajetra(LEC) i monotaktin-1 (MTN-1). Ovaj hemokin se ekspimira u jetri,timusuislezenii hemoatraktivan je zamonociteilimfocite.[3]Ćelijska ekspresija CCL16 može se snažno inducirati u monocitima pomoćuInterleukinIL-10,IFN-γi bakterijsilipopolisaharid.Njegovgennalazi se nahromosomu 17,kod ljudi, među skupinom ostalih CC-hemokina.[4]CCL16 izaziva učinke na ćelije interakcijom sa hemokinskim receptorima na površini ćelije, kao što suCCR1,CCR2,CCR5iCCR8.[5][6]
C-C motiv hemokinskih liganada 16 pronađen je u visokim nivoima u ljudskoj krvnoj plazmi.[7] CCL16 može biti koristan za promet eozinofila. Utvrđeno je da ovajligandima funkcionalni afinitet za H4 receptore koji se eksprimiraju ueozinofilimaimastocitima.[7] Pokazano je da ovaj hemokin suzbija brzu proliferaciju mijeloidnih progenitornih ćelija.[8]
Aminokiselinska sekvenca
[uredi|uredi izvor]Dužinapolipeptidnoglanca je 120aminokiselina,amolekulska težina13.600Da.[9].
10 | 20 | 30 | 40 | 50 | ||||
---|---|---|---|---|---|---|---|---|
MKVSEAALSL | LVLILIITSA | SRSQPKVPEW | VNTPSTCCLK | YYEKVLPRRL | ||||
VVGYRKALNC | HLPAIIFVTK | RNREVCTNPN | DDWVQEYIKD | PNLPLLPTRN | ||||
LSTVKIITAK | NGQPQLLNSQ |
- Simboli
C:Cistein
D:Asparaginska kiselina
E:Glutaminska kiselina
F:Fenilalanin
G:Glicin
H:Histidin
I:Izoleucin
K:Lizin
L:Leucin
M:Metionin
N:Asparagin
P:Prolin
Q:Glutamin
R:Arginin
S:Serin
T:Treonin
V:Valin
W:Triptofan
Y:Tirozin
Reference
[uredi|uredi izvor]- ^abcENSG00000275095 GRCh38: Ensembl release 89: ENSG00000275152, ENSG00000275095-Ensembl,maj 2017
- ^"Human PubMed Reference:".National Center for Biotechnology Information, U.S. National Library of Medicine.
- ^Youn BS, Zhang S, Broxmeyer HE, Antol K, Fraser MJ, Hangoc G, Kwon BS (juni 1998). "Isolation and characterization of LMC, a novel lymphocyte and monocyte chemoattractant human CC chemokine, with myelosuppressive activity".Biochemical and Biophysical Research Communications.247(2): 217–22.doi:10.1006/bbrc.1998.8762.PMID9642106.
- ^Nomiyama H, Fukuda S, Iio M, Tanase S, Miura R, Yoshie O (mart 1999). "Organization of the chemokine gene cluster on human chromosome 17q11.2 containing the genes for CC chemokine MPIF-1, HCC-2, HCC-1, LEC, and RANTES".Journal of Interferon & Cytokine Research.19(3): 227–34.doi:10.1089/107999099314153.PMID10213461.
- ^Nomiyama H, Hieshima K, Nakayama T, Sakaguchi T, Fujisawa R, Tanase S, Nishiura H, Matsuno K, Takamori H, Tabira Y, Yamamoto T, Miura R, Yoshie O (august 2001)."Human CC chemokine liver-expressed chemokine/CCL16 is a functional ligand for CCR1, CCR2 and CCR5, and constitutively expressed by hepatocytes".International Immunology.13(8): 1021–9.doi:10.1093/intimm/13.8.1021.PMID11470772.
- ^Howard OM, Dong HF, Shirakawa AK, Oppenheim JJ (august 2000). "LEC induces chemotaxis and adhesion by interacting with CCR1 and CCR8".Blood.96(3): 840–5.doi:10.1182/blood.V96.3.840.PMID10910894.
- ^abNakayama T, Kato Y, Hieshima K, Nagakubo D, Kunori Y, Fujisawa T, Yoshie O (august 2004)."Liver-expressed chemokine/CC chemokine ligand 16 attracts eosinophils by interacting with histamine H4 receptor".Journal of Immunology.173(3): 2078–83.doi:10.4049/jimmunol.173.3.2078.PMID15265943.
- ^"CCL16 C-C Motif Chemokine Ligand 16 [Homo Sapiens (Human)] Gene".National Center for Biotechnology Information, U.S. National Library of Medicine.
- ^"UniProt, O15467".Pristupljeno 28. 6. 2021.